BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma
BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma
Not yet recruiting · NCT07008053 · Registry updated 2025-06-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma | Marginal Zone Lymphomas | Not yet recruiting | Phase 2 | 2025-06-06 | NCT07008053 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 287 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fujian Cancer Hospital | Fuzhou | China | 55 |
| Hunan Cancer Hospital | Changsha | China | 87 |
| Shandong Cancer Hospital | Jinan | China | 31 |
| The Affiliated Hospital of Qingdao University | Qingdao | China | 48 |
| The Fourth Hospital of Hebei Medical University | Shijiazhuang | China | 33 |
| Tianjin Medical University Cancer Institute and Hospital | Tianjin | China | 36 |